CELLPROTHERA

Startup

CELLPROTHERA

Description

CELLPROTHERA develops pharmaceutical and biotechnology products designed for an innovative therapy based on autologous “adult” stem cells for the structural and functional regeneration of cardiac lesions after a severe infarction.

CELLPROTHERA

Address

12 RUE DU PARC MULHOUSE 68100
MULHOUSE, France

Contact

contact@cellprothera.com

Description

CELLPROTHERA develops pharmaceutical and biotechnology products designed for an innovative therapy based on autologous “adult” stem cells for the structural and functional regeneration of cardiac lesions after a severe infarction.

Matchmaking

Connect with CELLPROTHERA

This entity is yours?

Update information

Position on the value chain

With the ultimate aim to create a European alliance for bioproduction in Europe, organisations have joined forces with COBIOE. Discover who are our associates.

Bio-resources and biobanking
  • Cells, tissues and humanized xeno-organs
  • Biosamples
  • Viral, phage or bacterial specimen
Identification of biotherapies
  • Target identification
  • Target validation
  • Screening
Drug design
  • Drug assessment
  • Drug engineering
  • In vitro preclinical studies
Clinical validation
  • Clinical trials
  • In vivo preclinical validation
  • Pre-industrial scale production
Production
  • Upstream processes
  • Downstream processes
  • Quality control
Market access
  • CE mark / market authorisation
  • Payment / Reimbursement
  • Care pathways

TRL